메뉴 건너뛰기
Inflammopharmacology
Volumn 20, Issue 4, 2012, Pages 225-231
Dissolution and pharmacokinetics of a novel micronized aspirin formulation
Author keywords

Acetylsalicylic acid; Aspirin; Dissolution; Pharmacokinetic; Time to maximum plasma concentration
Indexed keywords

ACETYLSALICYLIC ACID; ALKA SEL; UNCLASSIFIED DRUG;
EID: 84864916714     PISSN: 09254692     EISSN: 15685608     Source Type: Journal    
DOI: 10.1007/s10787-011-0099-z     Document Type: Article
Times cited : (47)
References (8)
  • 1
    • 84864924312 scopus 로고    scopus 로고
    • Salt effect on a neutral species reaction: Acidic hydrolysis of aspirin
    • Al-Maaieh A, Aburub A (2005) Salt effect on a neutral species reaction: acidic hydrolysis of aspirin. AAPS J 7(S2)
    • (2005) AAPS J , vol.7
    • Al-Maaieh, A.1    Aburub, A.2
  • 2
    • 77954746792 scopus 로고    scopus 로고
    • ®: A sucessful example of formulation technology
    • Bröckel U, Meier W, Wagner G (eds) Wiley-VCH, Weinheim
    • ®: a sucessful example of formulation technology. In: Bröckel U, Meier W, Wagner G (eds) Product design and engineering: best practices. Wiley-VCH, Weinheim, pp 569-582
    • (2007) Product Design and Engineering: Best Practices , pp. 569-582
    • Buellesbach, R.1
  • 3
    • 0035997160 scopus 로고    scopus 로고
    • Efficacy and tolerability of nonprescription Ibuprofen versus Celecoxib for dental pain
    • DOI 10.1177/009127002401102830
    • Doyle G, Jayawardena S, Ashraf E, Cooper SA (2002) Efficacy and tolerability of non-prescription ibuprofen versus celecoxib for dental pain. J Clin Pharmacol 42:912-919 (Pubitemid 34803855)
    • (2002) Journal of Clinical Pharmacology , vol.42 , Issue.8 , pp. 912-919
    • Doyle, G.1    Jayawardena, S.2    Ashraf, E.3    Cooper, S.A.4
  • 4
    • 84864930184 scopus 로고    scopus 로고
    • Committee for medicinal products for human Use (chmp). Guideline on the investigation of bioequivalence
    • European Medicines Agency, London, 20 January 2010
    • European Medicines Agency (2010) Committee for Medicinal Products for Human Use (CHMP). Guideline on the Investigation of Bioequivalence. CPMP/QWP/EWP/1401/98 Rev. 1, London, 20 January 2010
    • (2010) CPMP/QWP/EWP/1401/98 Rev. , vol.1
  • 5
    • 84962124689 scopus 로고    scopus 로고
    • Dissolution testing of veterinary products. Dissolution testing of aspirin boluse
    • Fahmy R, Marnane W, Bensley D, Hollenbeck RG (2001) Dissolution testing of veterinary products. Dissolution testing of aspirin boluses. Dissolution Technol 8(1):8-14
    • (2001) Dissolution Technol , vol.8 , Issue.1 , pp. 8-14
    • Fahmy, R.1    Marnane, W.2    Bensley, D.3    Hollenbeck, R.G.4
  • 6
    • 0033938693 scopus 로고    scopus 로고
    • Over-The-Counter analgesics and antipyretics: A criticalassessment
    • Hersh EV, Moore PA, Ross GL (2000) Over-the-counter analgesics and antipyretics: a criticalassessment. Clin Ther 22:500-548
    • (2000) Clin Ther , vol.22 , pp. 500-548
    • Hersh, E.V.1    Moore, P.A.2    Ross, G.L.3
  • 7
    • 84864951526 scopus 로고    scopus 로고
    • Solubility: Particle size reduction is a promising approach to improve the bioavailability of lipophilic drugs
    • Neeti R, Murugesan SK, Nanjaian M (2011) Solubility: particle size reduction is a promising approach to improve the bioavailability of lipophilic drugs. Int J Recent Adv Pharm Res 1:8-18
    • (2011) Int J Recent Adv Pharm Res , vol.1 , pp. 8-18
    • Neeti, R.1    Murugesan, S.K.2    Nanjaian, M.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.